Clin Case Rep Int | Volume 6, Issue 1 | Review Article | Open Access

A Review on Assessment of Cardiovascular Risk in Type II Diabetes Patients by Using Mr-proANP and NT-proBNP

Sundar Singh SD^1*, Pithadia AB² and Lavanya S³
 

¹Department of Pharmacy Practice, C.L. Baid College of Pharmacy, India
²School of Pharmacy, Parul University, India
³Department of Pharmacy Practice, PSG College of Pharmacy, India

^*Correspondance to: S Daniel Sundar Singh 

Abstract

Aim: Cardiovascular disease is mainly affected to the patients with type 2 diabetes and the person with diabetic condition more prone to CVD than the person with non-diabetic condition. T2DM and CVD are correlated with each other with the condition of prolong lifestyle with improper diet and medication. Methodology: Moreover, the T2DM with no existence CVD are predicted to develop the CVD with high mortality rate than the non-diabetic patients. So that developing the biomarker in the prediabetic condition will helps to identify the HF event. Emerging research are involved in the identification of the biomarkers which may helpful to predict the CVD in diabetes patients. Results: At present, the more focus is turned towards the natriuretic peptides which can used to detect the CVD events in diabetes patients. Measurement of the BNP and ANP natriuretic peptides in the circulating bloods are recently used for diagnostic and prognostic of CVD. ANP are mostly used as an alternative for BNP in predicting heart failure, which was only observed with minor difference. Conclusion: This review deals with the information on the wide role of MR-proANP and NTproBNP as the potential diagnostic and prognostic in cardiovascular risk with T2DM.

Keywords:

Heart failure; Cardiovascular disease; Diabetes; Natriuretic peptide

Citation:

Sundar Singh SD, Pithadia AB, Lavanya S. A Review on Assessment of Cardiovascular Risk in Type II Diabetes Patients by Using Mr-proANP and NTproBNP. Clin Case Rep Int. 2022; 6: 1436.